Search clinical trials for: attention training, youth, latino

Total 3423 results

National Institute of Mental Health (NIMH)

Completed

Study of Children at Risk for Disruptive Behavior Disorders

Attention Deficit and Disruptive Behavior Disorders | Child Behavior Disorders | Passive-Aggressive Personality Disorder

United States
National Institute of Mental Health (NIMH)

Completed

Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia

Healthy | Schizophrenia | Brain Injury | Dementia | Mental Disorder

United States
National Institute of Mental Health (NIMH)

Completed

Genetic Aspects of Neurologic and Psychiatric Disorders

Schizophrenia | Bipolar Disorder | Attention Deficit Disorder With Hyperactivity | Mental Retardation | Mental Disorder Diagnosed in Childhood

United States
National Institute of Mental Health (NIMH)

Completed

Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders

Dementia

United States
National Institute of Mental Health (NIMH)

Completed

The Effect of Acetylcholine on Memory and Attention

Healthy | Alzheimer's Disease

United States
National Institute of Neurological Disorders and...

Completed

Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation

Attention Deficit Disorder With Hyperactivity

United States
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD (EMMA)

Attention Deficit Hyperactivity Disorder

Germany
University of California, Los Angeles

Completed

Mindfulness Meditation Training in HIV (MBSR)

HIV Infections

United States
Novartis

Completed

Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

Perioral Dermatitis

Germany
Sanofi

Completed

Extension to Study HMR1964A/3011 in Belgium

Diabetes Mellitus

Belgium
New Mexico VA Healthcare System
AstraZeneca

Completed

Schizophrenia Sensory Gating Deficit With Quetiapine

Schizophrenia

United States
Novartis

Completed

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

ADHD, ADD

United States
Cytogen Corporation

Unknown

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Prostatic Neoplasms

United States
Novartis

Completed

Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

ADHD

Germany
University of Ulm

Completed

The Influence of Having Breakfast on Cognitive Performance and Mood

Fasting

Germany
Eli Lilly and Company

Completed

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Japan
New River Pharmaceuticals

Completed

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
New River Pharmaceuticals

Completed

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
Hadassah Medical Organization

Completed

Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)

Dental Caries | Attention Deficit Disorder With Hyperactivity | Dental Occlusion, Traumatic

Israel
Eli Lilly and Company

Completed

Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine

Attention Deficit Hyperactivity Disorder

Canada, United States
Geha Mental Health Center
Clalit Health Services

Unknown

Methylphenidate in ADHD With Trichotillomania

ADHD | Trichotillomania

Israel
National Center for Complementary and Integrative...

Completed

Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
UMC Utrecht
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Prevention of Oppositional Defiant and Conduct Disorders in Preschool Children

Conduct Disorder | Oppositional Defiant Disorder

Netherlands
Federal University of Rio Grande do Sul
Novartis; Hospital de Clinicas de Porto Alegre; Honda do Brasil; Secretaria Nacional...

Unknown

Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents

Attention Deficit Hyperactivity Disorder

Brazil
Indiana University School of Medicine
Brown University; George Washington University; VA Boston Healthcare System

Completed

Research on Individualized Treatment for Alcoholism (RITA)

Alcohol Dependence

United States
Sykehuset Innlandet HF
Demensforbundet, Norway

Completed

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Dementia

Norway
Shalvata Mental Health Center

Unknown

Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points

Schizophrenia
Eunice Kennedy Shriver National Institute of Child...
National Institute of Mental Health (NIMH)

Completed

Improving Attention Skills of Children With Autism

Autism

United States
Tel-Aviv Sourasky Medical Center

Unknown

Inflammation in Children With Attention-Deficit/Hyperactivity Disorder (ADHD_CYTO)

Attention-Deficit/Hyperactivity Disorder

Israel
Eli Lilly and Company

Completed

Evaluation of Continuous Symptom Treatment of ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Attention Deficit Hyperactivity Disorder

China, Mexico, Korea, Republic of
Eli Lilly and Company

Completed

Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Safety Study in Outpatient Japanese Children With ADHD

Attention Deficit Hyperactivity Disorder

Japan
Eli Lilly and Company

Completed

A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD

Attention Deficit Hyperactivity Disorder

Netherlands
Eli Lilly and Company

Completed

Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Eli Lilly and Company

Completed

Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

Russian Federation
Eli Lilly and Company

Completed

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

Attention Deficit Hyperactivity Disorder | Comorbid Social Anxiety Disorder

United States, Puerto Rico
NeuroSearch A/S

Completed

Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

United States
UMC Utrecht
Netherlands Organisation for Scientific Research

Unknown

Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning

Attention Deficit Hyperactivity Disorder

Netherlands
UMC Utrecht

Unknown

Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Netherlands
Shaare Zedek Medical Center

Unknown

Procedural Learning in Participants With ADHD

Attention Deficit Hyperactivity Disorder

Israel
Eli Lilly and Company

Completed

Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

Attention Deficit Hyperactivity Disorder

United Kingdom
University Health Network, Toronto
The Hospital for Sick Children

Unknown

Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD

Attention Deficit Hyperactivity Disorder | Tourette's Syndrome

Canada
University of British Columbia
Eli Lilly and Company

Completed

Dietary Intake and Nutrient Status of Children With ADHD

Attention Deficit Hyperactivity Disorder

Canada
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder

Canada
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company

Completed

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Attention-Deficit/Hyperactivity Disorder

Canada

Search clinical trials for: attention training, youth, latino

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations